"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
| Descriptor ID |
D001859
|
| MeSH Number(s) |
C04.588.149 C05.116.231
|
| Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 8 | 1 | 9 |
| 1997 | 2 | 1 | 3 |
| 1998 | 4 | 3 | 7 |
| 1999 | 2 | 0 | 2 |
| 2000 | 3 | 2 | 5 |
| 2001 | 3 | 2 | 5 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 1 | 3 |
| 2005 | 5 | 1 | 6 |
| 2006 | 3 | 2 | 5 |
| 2007 | 4 | 1 | 5 |
| 2008 | 6 | 2 | 8 |
| 2009 | 6 | 1 | 7 |
| 2010 | 8 | 3 | 11 |
| 2011 | 8 | 2 | 10 |
| 2012 | 7 | 1 | 8 |
| 2013 | 8 | 0 | 8 |
| 2014 | 13 | 2 | 15 |
| 2015 | 18 | 1 | 19 |
| 2016 | 10 | 0 | 10 |
| 2017 | 14 | 2 | 16 |
| 2018 | 9 | 1 | 10 |
| 2019 | 12 | 2 | 14 |
| 2020 | 9 | 1 | 10 |
| 2021 | 8 | 1 | 9 |
| 2022 | 12 | 0 | 12 |
| 2023 | 10 | 0 | 10 |
| 2024 | 12 | 0 | 12 |
| 2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer. Cancer Discov. 2025 Apr 02; 15(4):818-837.
-
A Unique Case of Gross Hematuria in a Patient With Ewing Sarcoma. J Pediatr Hematol Oncol. 2025 Apr 01; 47(3):140-143.
-
Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clin Cancer Res. 2025 Feb 03; 31(3):457-465.
-
The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun. 2025 Feb 02; 16(1):1267.
-
Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Patients with Sarcoma. Ann Surg Oncol. 2025 Apr; 32(4):2883-2890.
-
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2024 Dec 01; 10(12):1645-1653.
-
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. Commun Biol. 2024 Nov 21; 7(1):1545.
-
The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer. A Hellenic Cooperative Oncology Group Phase II Study: Cabazitaxel in mCRPC patients with osseous metastases. Clin Genitourin Cancer. 2025 Feb; 23(1):102253.
-
Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer Foundation. Pract Radiat Oncol. 2025 Mar-Apr; 15(2):180-186.
-
Pediatric Ewing Sarcoma Presentation, Treatment, and Outcomes Across Sociodemographic Groups. J Surg Res. 2024 Nov; 303:322-331.